Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,591.04 74.77 0.52%
TOPIX 1,178.74 5.37 0.46%
HANG SENG 22,760.24 64.23 0.28%

Clavis Pharma ASA : Clavis Pharma ASA : Minutes from Extraordinary General Meeting



  Clavis Pharma ASA : Clavis Pharma ASA : Minutes from Extraordinary General
                                   Meeting

Oslo, Norway, May 3, 2013

Clavis Pharma ASA (OSE: CLAVIS), an Extraordinary General Meeting of Clavis
Pharma ASA was held on 2 May 2013 in Parkveien 53B, Oslo. Please find the
minutes of the Extraordinary General Meeting attached.

The Extraordinary General Meeting elected Martin Nes and Øystein Stray
Spetalen as new directors.

The Board of Directors of Clavis Pharma ASA consists of the following board
members:

·        Anders P. Wiklund (chairman)
·        Annette Clancy
·        Martin Nes
·        Øystein Stray Spetalen
·        Hilde H. Steineger

Contacts:

Gunnar Manum, CFO
Office : +47 24 11 09 71
Mobile : +47 95 17 91 90

E-mail :gunnar.manum@clavispharma.co 

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Minutes from Extraordinary General Meeting

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Clavis Pharma ASA via Thomson Reuters ONE
HUG#1698968
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement